Piedmont Community Health Collaborative, LLC 557 Brookdale Drive Statesville, North Carolina 28677 ACO Primary Contact Primary Contact Name Tyler Wilson Primary Contact Phone Number 704-874-4277 Primary Contact Email Address Tyler.wilson@piedmonthealthcare.com Organizational Information ACO participants: ACO s ACO in Joint Venture (Enter Y or N), LLC Y Optimed Hospitalists N Iredell Memorial Hospital, Incorporated Y, PA Y Family Care Center, PA Y ACO governing body: Member Last Name First Name Title/Position Member's Voting Power Membership Type Dr. Moran Joseph Chair 1 ACO Dr. Cash David Vice-Chair 1 ACO Dr. Pellegrino Yvette Secretary 1 ACO Guin Greg Treasurer 1 ACO Hartline Georgianne Director 1 Community Stakeholder Reed Jim Director 1 Medicare Beneficiary ACO TIN Legal Business Name/DBA, if Applicable
Dr. Ajjan Mahdi Director 1 ACO Dr. DeBerardinis Charles Director 1 ACO Snow John Director 1 ACO Dr. Harris Bruce Director 1 ACO Dr. Kimball Robert Director 1 ACO Dr. Perez Jose Director 1 ACO Dr. Nance Alisa Director 1 ACO Dr. Kuhlman Jeffrey Director 1 ACO Rush Ed Director 0 ACO Smith Jeff Director 0 ACO Wilson Tyler Director 0 Other Dr. Walker Laura Director 0 Other OptiMed Hospitalists Iredell Memorial Hospital Iredell Memorial Hospital Key ACO clinical and administrative leadership: Tyler Wilson ACO Executive Laura Walker Medical Director Kimberly Busenbark Compliance Officer Dr. Jose Perez Quality Assurance/Improvement Officer
Associated committees and committee leadership: Committee Name Committee Leader Name and Position Quality Dr. Jose Perez, Chair Health Information Technology/Health Information Dr. Yvette Pellegrino, Chair Management Finance Dr. Jeffrey Kuhlman, Chair Executive Dr. Joseph Moran, Chair Types of ACO participants, or combinations of participants, that formed the ACO: Partnerships or joint venture arrangements between hospitals and ACO professionals Shared Savings and Losses Amount of Shared Savings/Losses Shared Savings Distribution Quality Performance Results 2016 Quality Performance Results: ACO# Measure Name Rate ACO Mean 1 CAHPS: Getting Timely Care, Appointments, and Information 80.51 2 CAHPS: How Well Your Providers Communicate 93.01 3 CAHPS: Patients Rating of Provider 92.25 4 CAHPS: Access to Specialists 83.49 5 CAHPS: Health Promotion and Education 60.32 6 CAHPS: Shared Decision Making 75.40 7 CAHPS: Health Status/Functional Status 72.30 34 CAHPS: Stewardship of Patient Resources 26.97 8 Risk Standardized, All Condition Readmission 14.70 35 36 Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM) 18.17 All-Cause Unplanned Admissions for Patients with Diabetes 53.20
37 38 All-Cause Unplanned Admissions for Patients with Heart Failure 75.23 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 59.81 9 10 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) 9.27 14.53 11 39 13 14 15 Percent of PCPs who Successfully Meet Meaningful Use Requirements 82.72 Documentation of Current Medications in the Medical Record 87.54 Falls: Screening for Future Fall Risk 64.04 Preventive Care and Screening: Influenza Immunization 68.32 Pneumonia Vaccination Status for Older Adults 69.21 16 17 18 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow- Up Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention Preventive Care and Screening: Screening for Clinical Depression and Followup Plan 74.45 90.98 53.63 19 20 Colorectal Cancer Screening 61.52 Breast Cancer Screening 67.61 21 Preventive Care and Screening: Screening for High Blood Pressure and Follow- Up Documented 76.79 42 27 41 28 30 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 77.72 Diabetes Mellitus: Hemoglobin A1c Poor Control 18.24 Diabetes: Eye Exam 44.94 Hypertension (HTN): Controlling High Blood Pressure 70.69 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 85.05
31 33 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 88.67 79.67 Please note, the 40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples. Payment Rule Waivers No, our ACO does not use the SNF 3-Day Rule Waiver.